Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Savelyeva

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Blood|December 10, 2020
Novel players: tissue-resident memory B cellsNatalia Savelyeva, Christian H Ottensmeier
Biotechnology & Genetic Engineering Reviews|March 5, 2004
Engineering DNA vaccines that include plant virus coat proteinsNatalia Savelyeva, Delin Zhu, Freda K Stevenson
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2005
Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell helpNatalia Savelyeva, Catherine A King, Ellen S Vitetta, et al.
Blood|May 27, 2011
High-affinity memory B cells induced by conjugate vaccines against weak tumor antigens are vulnerable to nonconjugated antigenNatalia Savelyeva, Michael Shipton, Amy Suchacki, et al.
Cells|September 18, 2020
HNSCC: Tumour Antigens and Their Targeting by ImmunotherapyAdrian von Witzleben, Chuan Wang, Simon Laban, et al.
European Journal of Immunology|January 28, 2010
Bystander stimulation of activated CD4+ T cells of unrelated specificity following a booster vaccination with tetanus toxoidGianfranco Di Genova, Natalia Savelyeva, Amy Suchacki, et al.
Frontiers in Immunology|May 10, 2018
Targeting Head and Neck Cancer by VaccinationChuan Wang, James Dickie, Ruhcha V Sutavani, et al.
Vaccine|May 20, 2009
Amplification of immune responses against a DNA-delivered idiotypic lymphoma antigen by fusion to the B subunit of E. coli heat labile toxinCaleb G Chen, Yen-Ta Lu, Marie Lin, et al.
Cancers|July 27, 2022
Safety and Immunogenicity of Combined DNA-Polyethylenimine and Oral Bacterial Idiotypic Vaccine for Patients with B-Cell Non-Hodgkin Lymphoma: A Pilot StudyAlexander Meleshko, Nadzeya Piatrouskaya, Katsiaryna Vashkevich, et al.
Haematologica|July 3, 2014
The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergyGraham Packham, Serge Krysov, Alex Allen, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Blood|December 10, 2020
Novel players: tissue-resident memory B cellsNatalia Savelyeva, Christian H Ottensmeier
Biotechnology & Genetic Engineering Reviews|March 5, 2004
Engineering DNA vaccines that include plant virus coat proteinsNatalia Savelyeva, Delin Zhu, Freda K Stevenson
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2005
Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell helpNatalia Savelyeva, Catherine A King, Ellen S Vitetta, et al.
Blood|May 27, 2011
High-affinity memory B cells induced by conjugate vaccines against weak tumor antigens are vulnerable to nonconjugated antigenNatalia Savelyeva, Michael Shipton, Amy Suchacki, et al.
Cells|September 18, 2020
HNSCC: Tumour Antigens and Their Targeting by ImmunotherapyAdrian von Witzleben, Chuan Wang, Simon Laban, et al.
European Journal of Immunology|January 28, 2010
Bystander stimulation of activated CD4+ T cells of unrelated specificity following a booster vaccination with tetanus toxoidGianfranco Di Genova, Natalia Savelyeva, Amy Suchacki, et al.
Frontiers in Immunology|May 10, 2018
Targeting Head and Neck Cancer by VaccinationChuan Wang, James Dickie, Ruhcha V Sutavani, et al.
Vaccine|May 20, 2009
Amplification of immune responses against a DNA-delivered idiotypic lymphoma antigen by fusion to the B subunit of E. coli heat labile toxinCaleb G Chen, Yen-Ta Lu, Marie Lin, et al.
Cancers|July 27, 2022
Safety and Immunogenicity of Combined DNA-Polyethylenimine and Oral Bacterial Idiotypic Vaccine for Patients with B-Cell Non-Hodgkin Lymphoma: A Pilot StudyAlexander Meleshko, Nadzeya Piatrouskaya, Katsiaryna Vashkevich, et al.
Haematologica|July 3, 2014
The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergyGraham Packham, Serge Krysov, Alex Allen, et al.
Pageof 3